MTND4P12: A Drug Target / Disease Biomarker (G100293090)

Target Name: MTND4P12

NCBI ID: G100293090

MTND4P12

Other Name(s): MT-ND4 pseudogene 12

MTND4P12: A Drug Target / Disease Biomarker

MTND4P12 is a protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. The protein is known for its role in the formation of beta-amyloid plaques, which are a hallmark of Alzheimer's disease and are thought to contribute to the development of the disease.

In addition to its role in the formation of beta-amyloid plaques, MTND4P12 has also been shown to play a role in the regulation of several important cellular processes in the brain, including the regulation of neurotransmitter signaling, the regulation of inflammation, and the regulation of cell survival.

As a potential drug target, MTND4P12 is an attractive target for researchers because of its involvement in the development and progression of several neurological disorders, including Alzheimer's disease. By targeting this protein, researchers may be able to develop new treatments for these disorders that specifically target the MTND4P12 protein.

One approach to targeting MTND4P12 is to use small molecules that can inhibit the activity of the protein. Researchers have identified several small molecules that have been shown to inhibit the activity of MTND4P12 and have evaluated their potential as drug candidates for the treatment of Alzheimer's disease.

Another approach to targeting MTND4P12 is to use antibodies that specifically target the protein. Researchers have been able to generate antibodies that are specific for MTND4P12 and have used these antibodies to label the protein in the brain and visualize it in live animals. This has allowed researchers to see how the protein is distributed and how it interacts with other proteins in the brain.

While these approaches are still in the early stages of research, they demonstrate the potential of MTND4P12 as a drug target for the treatment of Alzheimer's disease. By developing new treatments that specifically target this protein, researchers may be able to slow the progression of the disease and potentially even reverse its effects.

In conclusion, MTND4P12 is a protein that is expressed in the brain and is involved in the development and progression of several neurological disorders, including Alzheimer's disease. While more research is needed to fully understand the role of this protein in the disease, its potential as a drug target is an exciting area of research that has the potential to lead to new treatments for Alzheimer's disease.

Protein Name: MT-ND4 Pseudogene 12

The "MTND4P12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTND4P12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets